Surrozen (SRZN) Return on Sales (2024 - 2026)
Surrozen (SRZN) posted quarterly Return on Sales of 0.07% for Q1 2026, up 8.0% year-over-year from 0.06% in Q1 2025, and up 62.08% quarter-over-quarter from 0.17% in Q4 2025.
Surrozen (SRZN) Return on Sales (2024 - 2026) Analysis & Trends
Surrozen's Return on Sales history runs 3 years deep, the most recent figure standing at 0.07% for Q1 2026.
- In Q1 2026, Return on Sales rose 8.0% year-over-year to 0.07%; the TTM figure through Mar 2026 stood at 0.1% (down 3.0% YoY), while the FY2025 annual figure was 0.15%, down 8.0% from the prior year.
- Return on Sales for Q1 2026 stood at 0.07%, up from 0.17% in the prior quarter.
- The five-year high for Return on Sales was 0.0% in Q3 2024, with the low at 0.92% in Q4 2024.
- The 3-year median for Return on Sales is 0.17% (2025), against an average of 0.24%.
- Peak annual rise in Return on Sales reached 75 bps in 2025, while the deepest fall reached 19 bps in 2025.
- Surrozen's Return on Sales stood at 0.92% in 2024, then jumped by 81 bps to 0.17% in 2025, then soared by 62 bps to 0.07% in 2026.
- Business Quant data shows SRZN's Return on Sales at 0.07% in Q1 2026, 0.17% in Q4 2025, and 0.19% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 0.00% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | Surrozen | 281.63 Mn | 281.63 Mn | - | -0.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.05% |
| Mar 31, 2026 | -0.07% |
| Dec 31, 2025 | -0.17% |
| Sep 30, 2025 | -0.19% |
| Jun 30, 2025 | -0.17% |
| Mar 31, 2025 | -0.15% |
| Dec 31, 2024 | -0.92% |
| Sep 30, 2024 | 0.00% |